2002
DOI: 10.1002/rcm.616
|View full text |Cite
|
Sign up to set email alerts
|

Hydrogen/deuterium exchange for higher specificity of protein identification by peptide mass fingerprinting

Abstract: Genome sequencing projects produce large amounts of information that could be translated into potential protein sequences. Such amounts of material continuously increase protein database sizes. At present, 22 times more protein sequences are available in the SWISS-PROT and TrEMBL databases than 8 years ago in SWISS-PROT. One of the methods of choice for protein identification makes use of specific endoproteolytic cleavage followed by matrix-assisted laser desorption/ionisation mass spectrometric (MALDI-MS) ana… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2002
2002
2007
2007

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 18 publications
(5 citation statements)
references
References 51 publications
0
5
0
Order By: Relevance
“…Subsequent studies need to include further separation or purification, digestion by known proteases, characterization of digests by MALDI-TOF MS, comparison of results to protein databases, then verification by an independent technique, such as immunoblotting. The unique identification of low mass proteins or peptides is more difficult than that of high mass proteins (because of fewer entries in protein databases), but more information is continually becoming available (Bienvenut et al, 2002;Zhu et al, 2004). The discovery of low mass proteins or peptides is important; data obtained from SELDI-TOF MS studies are beginning to indicate that characteristic protein degradation patterns occur in many pathological states and that the biomarkers of interest are frequently fragments of protein degradation (Nomura et al, 2004;Paradis et al, 2005;Petricoin and Liotta, 2004).…”
Section: Discussionmentioning
confidence: 99%
“…Subsequent studies need to include further separation or purification, digestion by known proteases, characterization of digests by MALDI-TOF MS, comparison of results to protein databases, then verification by an independent technique, such as immunoblotting. The unique identification of low mass proteins or peptides is more difficult than that of high mass proteins (because of fewer entries in protein databases), but more information is continually becoming available (Bienvenut et al, 2002;Zhu et al, 2004). The discovery of low mass proteins or peptides is important; data obtained from SELDI-TOF MS studies are beginning to indicate that characteristic protein degradation patterns occur in many pathological states and that the biomarkers of interest are frequently fragments of protein degradation (Nomura et al, 2004;Paradis et al, 2005;Petricoin and Liotta, 2004).…”
Section: Discussionmentioning
confidence: 99%
“…To better understand what factors influence the fragmentation mechanism, we also investigated replacing the N-terminal and C-terminal variables indicating the amino acid residues either side of the fragmentation site with a description of the essential physical and chemical properties of the residues, thus leading to a physicochemical regression model. The properties of amino acids readily available in the literature include volume of the residue in solution, the accessible surface area of the residue, two different scales of hydrophobicity (a measure of their relative affinity for water), , and a measure of how many hydrogen bonds could be formed by each residue . We decided to incorporate both hydrophobicity scales, normalized to a standard normal distribution (mean = 0, SD = 1) into the model for intensity as they measure slightly different aspects of hydropathy.…”
Section: Methodsmentioning
confidence: 99%
“…With increasing database sizes (SWISS-PROT release 40.11 and TrEMBL release 19.8 contain sequence data and annotation of 700 000 proteins), and therefore an increasing likelihood of false positive identifications, protein identification by peptide mass fingerprinting (PMF) alone is becoming more and more difficult [1]. It is indeed quite common for PMF tools not to be able to find matching theoretical peptides for a few of the less intense peaks that were detected and submitted to the identification process.…”
Section: Introductionmentioning
confidence: 99%